Chris Villemarette, Trial Lawyer ChrisVillemarette Trial Lawyers
Toll Free: 866-574-4740 | Local: 337-205-7593
Toll Free: 866-574-4740 |
Local: 337-205-7593

Personal Injury: Pharmaceuticals sued over a baby born addicted

A mother has filed a class action lawsuit on behalf of her child and others who are born addicted to opioids. The suit filed in Louisiana names several pharmaceutical companies and distributors, and the plaintiff is asking for monetary damages to cover long-term treatment. The mother claims she became addicted to opioids while being treated for a personal injury sustained in a car accident.

The child in the lawsuit was born with a condition known as Neonatal Abstinence Syndrome. It is diagnosed in babies who have fetal exposure to drugs by their mothers in the womb. The condition does not set in until after birth. In three short years of life, the child has undergone hearing, speech and behavioral therapy to manage the effects of NAS.

The federal social insurance program tracks the number of children born with NAS. They claim the number of babies born addicted is high based on the number of Medicaid recipients who were consuming opioids during pregnancy. According to figures cited, one out of five Medicaid mothers consumed opioids at some time during their pregnancy. It is estimated that a baby is born every 25 minutes in the U.S. suffering from opioid withdrawal.

The birth of a child should be one of the happiest times in a woman's life. Many vulnerable babies are suffering because drug companies failed to disclose the addictive nature of opioids. Short-term and long-term care of babies born with NAS has been overlooked until now. In Louisiana, mothers whose babies are suffering from opioid addiction may benefit from consulting with a personal injury attorney. A lawyer can investigate and determine if there is just cause to pursue a lawsuit.

Source: nola.com, "The family of a Louisiana infant born addicted to opioids is suing drug makers", Maria Clark, Feb. 27, 2018

No Comments

Leave a comment
Comment Information